Adverse health effects of indoor moulds

Arhiv za Higijenu Rada i Toksikologiju

Volumn 63, Issue 4, 2012, Pages 545-549

  Piecková, Elena ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Inflammation; Mycotoxins; Respiratory tract; Sick building syndrome; Volatile organic compounds

Indexed keywords

ACETALDEHYDE; ALTERNARIOL; CITRININ; FORMALDEHYDE; HEMOLYSIN; HEPTANE; LIMONENE; PROPANOL; TOLUENE; TRICHODERMIN; TRICHODERMOL; TRICHOTHECENE DERIVATIVE; XYLENE; DUST; MYCOTOXIN; PARTICULATE MATTER;

BLEEDING; CARCINOGENICITY; CYTOTOXICITY; FUNGUS SPORE; HUMAN; INFLAMMATION; LUNG HEMORRHAGE; LUNG INJURY; MOULD; MUTAGENICITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; REVIEW; SWELLING; TERATOGENICITY; ADVERSE EFFECTS; ANALYSIS; DUST; FUNGUS; INDOOR AIR POLLUTION; ISOLATION AND PURIFICATION; PARTICULATE MATTER; SICK BUILDING SYNDROME;

TRACHICHTHYIDAE;

AIR POLLUTION, INDOOR; DUST; FUNGI; HEMOLYSIN PROTEINS; HUMANS; MYCOTOXINS; PARTICULATE MATTER; SICK BUILDING SYNDROME;

EID: 84875788514     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-63-2012-2221     Document Type: Review

References (31)

1. Kröling P. [Sick Building Syndrom. Symptome, Ursachen, und Prophylaxe gebäudebedingter Gesundheitsstörungen, in German].Allergologie 1998;21:180-91.
2. Burge PS. Sick building syndrome. Occup Environ Med 2004;61:185-90.
3. Yang G-H, Jarvis, BB, Chung Y-J, Pestka JJ. Apoptosis induction by satratoxins and other trichothecene mycotoxins: Relatinship to ERK, p38 MAPK, and SAPK/JNK activation. Toxicol Appl Pharmacol 2000;164:149-60.
4. Jaakkola MS, Piipari R, Jaakkola JJK. Occupation and asthma: A populatin-based incident case-control study. Am J Epidemiol 2003;158:981-7.
5. Crook B, Burton NC. Indoor moulds, sick building syndrome and building related illness. Fungal Biol Rev 2010;24:106-13.
6. Piecková E, Wilkins K. Airway toxicity of house dust and its fungal composition. Ann Agric Environ Med 2004;11:67-73.
7. Piecková E, Jesenská Z. Štúdium mykotickej kontaminácie omietok in vitro [Evaluation of in vitro fungal contamination of plasters, in Slovak]. Hygiena 2000;45:37-41.
8. Piecková E, Pivovarová Z, Sternová Z, Droba E. Building materials vs. fungal colonization - model experiments. In: Brebbia CA, editor. Environmental Health Risk IV. Southampton: WitPress; 2007. p. 71-8.
9. Garrett MH, Rayment PR, Hooper MA, Abramson MJ, Hooper BM. Indoor airborne fungal spores, house dampness and associations with environmental factors and respiratory health in children. Clin Exp Allergy 1998;28:459-67.
10. Hendry KM, Cole EC. A review of mycotoxins in indoor air. J Toxicol Environ Health 1993;38:161-82.
11. Larsen FO, Clementsen P, Hansen M, Maltbaek N, Ostenfeldt-Larsen T, Nielsen KF, Gravesen S, Skov PS, Norn S. Volatile organic compounds from the indoor mould Trichoderma viride cause histamine release from human bronchoalveolar cells. Inflamm Res 1998;47(Suppl 1):S5-6.
12. Korpi A, Pasanen A-L, Pasanen P, Kalliokoski P. Microbial growth and metabolism in house dust. Int Biodeterior Biodegrad 1997;40:19-27.
13. Perry LP, Iwata M, Tazelaar HD, Colby TV, Yousem SA. Pulmonary mycotoxicosis: A clinicopathologic study of three cases. Mod Pathol 1998;11: 432-6.
14. Kuhn DM, Ghannoum MA. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: Infectious disease perspective. Clin Microbiol Rev 2003;16:144-72.
15. Andersen B, Nielsen KF, Jarvis B. Characterisation of morphologically, chemically and physiologically different Stachybotrys species from water-damaged buildings. Mycologia 2002;94:392-403.
16. Hintikka E-L. The role of Stachybotrys in the phnomenon known as sick building syndrome. In: Straus DC, editor. Advances in applied microbiology. Vol 55. San Diego: Elsevier Academic Press; 2004. p. 155-73.
17. Nielsen KF, Hansen MO, Larsen TO, Thrane U. Production of trichothecene mycotoxins on water damaged gypsum boards in Danish buildings. Int Biodeterior Biodegrad 1998;42:1-7.
18. Piecková E, Hurbánková M, Černá S, Pivovarová Z, Kováčiková Z. Pulmonary cytotoxicity of secondary metabolites of Stachybotrys chartarum (Ehrenb.) Hughes. Ann Agric Environ Med 2006;13:259-62.
19. Piecková E, Hurbánková M, Černá S, Lišková A, Kováčiková Z, Kollá riková Z, Wimmerová S. Inflammatory and haematotoxic potential of indoor Stachybotrys chartarum (Ehrenb.) Hughes metabolites. Arh Hig Rada Toksikol 2009;60:401-9.
20. Rao CY, Burge HA, Brain JD. The time course of responses to intratracheally instilled toxic Stachybotrys chartarum spores in rats. Mycopathologia 2000;149:27-34.
21. Ren P, Ahearn DG, Crow Jr SA. Mycotoxins of Alternaria alternata produced on celing tiles. J Ind Microbiol Biotechnol 1998;20:53-4.
22. Gravesen S, Frisvad JC, Samson RA. Microfungi. Copenhagen: Munksgaard; 1994.
23. Nielsen KF, Thrane U, Larsen TO et al. Production of mycotoxins on artificially inoculated building materials. Int Biodeter Biodegrad 1998;42:9-16.
24. Gravesen S, Nielsen PA, Iversen R, Nielsen KF. Microfungal contamination of damp buildings - examples of risk constructions and risk materials. Environ. Health Perspect 1999;107(Suppl 3):505-8.
25. Wilkins K, Piecková E. Detection of ciliostatic activity in fungal growth on building materials. Environ Sci Pollut Res 2002;9:105-6.
26. Jesenská Z, Bernát D. Efects of mycotoxins on in vitro movement of tracheal cilia from one-day-old chicks. Folia Microbiol 1994;39:155-8.
27. Piecková E. In vitro toxicity of indoor Chaetomium Kunze ex Fr. Ann Agric Environ Med 2003;10:9-14.
28. Piecková E, Kunová Z. Indoor fungi and their ciliostatic metabolites. Ann Agric Environ Med 2002;9:59-63.
29. Nikulin M, Reijula K, Jarvis BB, Hintikka E-L. Experimental lung mycotoxicosis in mice induced by Stachybotrys atra. Int J Exp Pathol 1996;77:213-8.
30. Nikulin M, Reijula K, Jarvis BB, Veijalainen P, Hintikka EL. Effects of intranasal exposure to spores of Stachybotrys atra in mice. Fundam Appl Toxicol 1997;35:182-8.
31. Vesper SJ, Magnuson ML, Dearborn D, Yike I, Haugland RA. Initial characterization of the hemolysin stachylysin from Stachybotrys chartarum. Infect Immunol 2001;69:912-6.